Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

33.55
-1.1900-3.43%
Volume:527.67K
Turnover:18.05M
Market Cap:3.73B
PE:-23.45
High:35.09
Open:34.78
Low:33.51
Close:34.74
52wk High:41.14
52wk Low:9.15
Shares:111.19M
Float Shares:109.51M
Volume Ratio:0.63
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:15.60
PE(LYR):-21.92

Loading ...

RAmylyx Pharma Q2 EPS $(0.39) Misses $(0.36) Estimate, Cash & Equivalents $279.8M. Cash runway Expected To Fund Operations Till 2028

Benzinga Earnings
·
Aug 06

Amylyx Pharmaceuticals Q2 EPS USD -0.39 Vs. IBES Estimate USD -0.36

Reuters
·
Aug 06

Amylyx Pharmaceuticals, - Cash Runway Expected to Fund Operations into 2028

THOMSON REUTERS
·
Aug 06

Press Release: Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 06

Amylyx Pharmaceuticals Inc Expected to Post a Loss of 36 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Press Release: Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026

Dow Jones
·
Aug 03

Amylyx Pharmaceuticals Schedules Quarterly Results Call

Reuters
·
Aug 03

Amylyx price target raised to $26 from $20 at Citi

TIPRANKS
·
Aug 03

TAKAOKA TOKO Sets Out FY2026 Q1 Financial Overview for Its Energy Network Business

TIPRANKS
·
Jul 30

Fuel costs on the rise as latest geopolitical turmoil drives up crude oil prices

Bloomberg
·
Jul 24

Goldman Sachs Eyes $120 Oil Spike if Middle East Shipping Risks Continue

TIPRANKS
·
Jul 21

Hengyi Petrochemical Notes Product Prices Follow Crude Oil, But Profits Depend on Spreads

Deep News
·
Jul 20

Trade Alert: Chief Legal Officer & General Counsel Of Amylyx Pharmaceuticals Gina Mazzariello Has Sold Stock

Simply Wall St.
·
Jul 15

Amylyx Chief Legal Officer Gina Mazzariello Sells USD 539,362 of Common Stock

Reuters
·
Jul 14

Kodiak Gas Services, Baker Hughes Announce Multi-Year Gas Turbine Order Agreement to Support U.S. Data Center Growth

GlobeNewswire
·
Jul 08

Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)

TIPRANKS
·
Jul 02

Could Amylyx (AMLX) ALS Safety Data Quietly Reframe Its Neurodegeneration Versus Endocrine Strategy?

Simply Wall St.
·
Jun 27

Amylyx Pharmaceuticals is Maintained at Buy by Guggenheim

Dow Jones
·
Jun 25

Amylyx reports clean safety in lowest-dose cohort of Phase 1 LUMINA trial of ALS drug AMX0114

Reuters
·
Jun 23

Amylyx Pharmaceuticals to Present Data From First-in-Human, Dose-Ranging Phase 1 Lumina Trial of Amx0114 in ALS at Encals 2026

THOMSON REUTERS
·
Jun 23